Starting Dose for Naltrexone
For opioid dependence, start with 25 mg once daily; if no withdrawal signs occur, increase to 50 mg daily thereafter. For alcohol dependence, start directly with 50 mg once daily. 1
Critical Pre-Treatment Requirements
Before initiating naltrexone, patients must be opioid-free to avoid precipitated withdrawal, which can be severe and potentially dangerous:
- Minimum 7-10 days opioid-free for short-acting opioids
- Up to 2 weeks for patients transitioning from buprenorphine or methadone 1
- Consider naloxone challenge test if occult opioid dependence is suspected (IV: 0.2 mg, then 0.6 mg; or SC: 0.8 mg) 1
Warning: Patients switching from opioid agonist therapy (methadone, buprenorphine) may experience severe precipitated withdrawal. Healthcare providers must be prepared to manage withdrawal symptomatically with non-opioid medications. 1
Specific Dosing by Indication
Opioid Dependence
- Initial dose: 25 mg once daily 1
- Monitor for withdrawal signs
- If tolerated without withdrawal, advance to 50 mg once daily 1
- This 50 mg daily dose provides adequate blockade of parenterally administered opioids 1
Alcohol Dependence
- Standard dose: 50 mg once daily 1
- This dosing regimen demonstrated efficacy in placebo-controlled trials for up to 12 weeks 1
- Alternative dosing for supervised administration: 50 mg weekdays with 100 mg Saturday, or 100 mg every other day, or 150 mg every third day 1
- Caution: Doses above 50 mg carry higher risk of hepatocellular injury 1
The 2013 American Family Physician guideline confirms these dosing recommendations, noting naltrexone is available as 50 mg tablets taken daily, or alternatively 100 mg on Mondays/Wednesdays and 150 mg on Fridays, with a 380 mg monthly injection (Vivitrol) also available. 2
Essential Monitoring and Safety Considerations
Liver function tests should be obtained at baseline and every 3-6 months, as naltrexone has been associated with hepatocellular injury at supratherapeutic doses. 2
Contraindications:
- Active opioid use or dependence (risk of precipitated withdrawal)
- Acute opioid withdrawal
- Current need for opioid analgesics
- Acute hepatitis or liver failure
- Positive urine opioid screen 1
Common side effects include nausea (particularly in younger patients, females, and those with shorter abstinence periods), headache, dizziness, and arthralgia. 3, 4 Nausea risk is higher with shorter abstinence duration before starting naltrexone, especially in lighter drinkers. 4
Clinical Context and Effectiveness
Naltrexone works as a mu-opioid receptor antagonist, blocking the euphoric effects of opioids and reducing alcohol craving. 2 However, its effectiveness is highly dependent on patient motivation and comprehensive treatment programs—it should never be used as monotherapy. 1
For alcohol dependence, naltrexone has shown benefit in maintaining abstinence when combined with counseling, though evidence quality varies. 5, 6 The 2010 Hepatology guideline on alcoholic liver disease recommends naltrexone or acamprosate in combination with counseling to decrease relapse likelihood in patients who achieve abstinence. 5
For opioid dependence, naltrexone has demonstrated effectiveness primarily in highly motivated populations (such as healthcare professionals), with more limited success in general populations. 2 Patients discontinuing naltrexone face increased risk of opioid overdose due to decreased tolerance. 2
Critical pitfall: Naltrexone cannot be used in patients requiring opioid pain management, as it will block analgesic effects and potentially precipitate withdrawal in opioid-dependent individuals. 2 For perioperative management, oral naltrexone should be held 2-3 days before surgery if opioids will be needed; extended-release naltrexone requires 24-30 days. 7